Pacific Health Emergency

The Pacific faces the world's highest diabetes rate. GlucoToq is built for this fight.

In Fiji, 1 in 3 adults has diabetes. In Tonga and Samoa, it's even higher. Health systems across the Pacific are overwhelmed. GlucoToq brings AI-powered, affordable, continuous diabetes management to the communities that need it most.

Diabetes Control Informatics: diabetes information collected to support informed advice and care.

Health worker testing a patient's blood glucose with a glucose meter
Every 9 seconds, diabetes claims a life. In the Pacific, the rate is 3x the global average. Most are preventable.
589M
Adults with diabetes
1 in 9 worldwide
853M
Projected by 2050
+45% increase
$1T+
Annual health spend
338% increase in 17 years
3.4M
Deaths per year
1 every 9 seconds
The Pacific Crisis

The Pacific Islands are ground zero for the global diabetes epidemic.

No region on Earth faces a more urgent diabetes burden than the Pacific. The numbers are not just alarming — they are a call to action.

🌎 The Pacific Diabetes Emergency

The Pacific Island nations have the highest age-standardised diabetes prevalence in the world. In Fiji, diabetes is the leading cause of death, blindness, and amputation. Health systems are stretched thin across remote island chains with limited specialist access.

30%
Adult diabetes rate in Fiji — 3x the global average
47%
Of adults in American Samoa have diabetes — the world's highest rate
80%
Of Pacific amputations are diabetes-related — often preventable
The Global Crisis

Health systems are not built for 589 million chronic patients.

Diabetes is no longer a disease of wealthy nations. It is a global emergency that strikes hardest where resources are scarcest.

⚠

The Undiagnosed Epidemic

252 million people have diabetes and don't know it. That's 42.8% of all cases globally. They walk into hospitals with advanced complications that could have been prevented.

$

The Economic Tsunami

Diabetes will cost the global economy $10.2 trillion between 2020 and 2050. Including informal caregiving, the burden explodes to $78.8 trillion — equivalent to 1.7% of global GDP.

🌎

The Equity Gap

3 in 4 adults with diabetes live in low- and middle-income countries. 90% of untreated cases are in these regions. Less than 5% of countries meet WHO diagnosis targets.

The Cost

Hospitalizations and complications are bankrupting budgets.

When diabetes is unmanaged, the bill comes due in emergency rooms, amputation wards, and dialysis centers.

Nurse testing patient blood glucose
$10.2T

Global economic burden (2020-2050)

Direct medical costs, lost productivity, and premature mortality across 204 countries.

$1.3T

Annual global cost (2015 baseline)

Already 1.8% of global GDP. Projected to hit $2.5 trillion by 2030 even if targets are met.

84%

Higher heart failure risk

Type 2 diabetes patients face dramatically elevated cardiovascular risk — the leading driver of hospitalization costs.

59%

Of diabetics are untreated

Almost 450 million adults receive no glucose-lowering medication. Complications are inevitable.

🔴 The Diagnosis Gap is a Death Sentence

Only 8 countries out of 215 meet the WHO target of diagnosing 80% of people with diabetes. In Africa, the gap is 50 percentage points below target. In the Western Pacific, it is 32 points below.

42.8%

Undiagnosed globally

252 million adults walk around with untreated diabetes, developing irreversible complications.

58.7%

Undiagnosed in low-income

Compared to 28.9% in high-income countries. Poverty and diabetes form a deadly feedback loop.

206M

In middle-income countries

81.8% of all undiagnosed cases. Half of them live in just three nations: China, India, Indonesia.

Trusted by health systems & partners worldwide
The Solution

GlucoToq turns reactive crisis care into proactive daily management.

An AI-powered platform that connects patients, devices, and health systems in one intelligent loop — designed for connectivity-challenged, resource-limited environments.

1

Continuous Glucose Monitoring

Real-time sync with Dexcom G7, FreeStyle Libre, and Apple Watch. Patients and providers see the same data, instantly. No more blind spots between clinic visits — critical when specialists are on another island.

2

AI-Powered Weekly Reports

GPT-4 pattern detection identifies trends humans miss — breakfast spikes, hydration correlations, nighttime lows. Actionable insights, not just raw numbers. Works offline and syncs when connectivity returns.

3

One-Tap Logging

Glucose, food, water, insulin — all in one place. Barcode scanning for carbs. Smart reminders for medication. The friction of daily management disappears, even for patients with limited digital literacy.

4

Clinician-Ready PDFs

Auto-generated weekly reports export directly to PDF. Endocrinologists get structured data, trend analysis, and AI recommendations — no more fragmented notebooks. Share via WhatsApp, email, or print.

Nutrition & Care

An in-house dietetics team that designs diets around the food people actually eat.

Calorie monitoring by our in-house dietetics team

GlucoToq dietitians monitor each patient's calorie intake alongside their glucose readings, so advice is based on real data rather than guesswork.

Diets built on local and commonly eaten food

Meal plans are designed around locally grown and widely eaten foods: dalo, cassava, breadfruit, bananas and other tropical fruit, and fresh fish, with simple swaps and preparation tips that ease glucose spikes.

Data collected through calls to patients

Part of our data collection is done by phone. Our team calls patients to record meals, glucose readings and symptoms, and automated voice check-ins reach people on basic phones. This information supports informed advice and care.

Bananas, pineapple, papaya and mango: local tropical fruit
Local staples: bananas and tropical fruit.
Voices from the Front Line

What patients, doctors, and health leaders are saying.

Real stories from the communities GlucoToq is built to serve.

“

Before GlucoToq, I was checking my sugar once a week and guessing my insulin. Now I see patterns I never noticed. My HbA1c dropped from 10.2 to 7.1 in three months. My doctor in Suva can see my data without me flying there.

MK
Mereoni Koro
Type 2 Patient, Nadi, Fiji
“

We piloted GlucoToq across 12 rural health centres in Fiji. Patient engagement tripled. Emergency admissions for DKA dropped 40% in six months. This is the kind of digital health intervention that actually scales in the Pacific.

JT
Dr. Jemesa Tudravu
Permanent Secretary for Health, Fiji
“

My 11-year-old son has Type 1. With GlucoToq Family, I can see his glucose at school in real time. The AI warned us about nighttime lows we were missing. It has given us something we never had before: peace of mind.

LN
Lusi Nabou
Mother & Caregiver, Lautoka, Fiji
“

We evaluated six diabetes platforms for our Pacific Island health network. GlucoToq was the only one that worked reliably on 3G, integrated with both Dexcom and FreeStyle, and generated clinician-ready reports in under 30 seconds.

SW
Dr. Sarah Williams
Regional Health Advisor, Pacific Community (SPC)
“

The weekly AI report told me my post-lunch spikes were linked to dehydration, not just carbs. I increased my water intake and my time-in-range jumped from 58% to 81%. The app pays for itself in avoided complications.

TP
Tevita Peni
Type 1 Patient & Pro User, Suva, Fiji

Download GlucoToq Today

Available on iOS and Android. Start your free 7-day trial of Pro — no credit card required. Works offline, syncs when connected.

Pricing

Simple pricing. Powerful results. 7 days free.

Start with Pro free for one week. No credit card. No commitment. Just better glucose control.

Free

$0/mo
Forever free
  • Manual glucose logging
  • Basic charts & trends
  • Food & insulin tracking
  • Water intake monitor
  • 7-day data history
Get started

Family

$14.99/mo
Up to 4 profiles
  • Everything in Pro, plus:
  • Up to 4 family profiles
  • Caregiver dashboard
  • Shared family reports
  • Pediatric mode & alerts
  • Priority support
Start free trial

Clinic

$49/mo
Per practice
  • Everything in Pro, plus:
  • Patient population dashboard
  • Bulk PDF report generation
  • Care team collaboration
  • EHR integration ready
  • HIPAA/GDPR compliance
Contact sales
Comparison

Why GlucoToq wins against every competitor.

We built what others missed: AI intelligence, true CGM integration, and clinician-ready reports in one affordable platform.

Feature GlucoToq mySugr Glucose Buddy Glooko Happy Bob
Price (Premium) $9.99/mo $2.99/mo $14.99/mo Free $9.99/mo
Free trial 7 days Pro Limited free Ad-supported only Free forever 1 week
CGM Integration Dexcom + Libre Accu-Chek only Dexcom G5/G6 100+ devices Dexcom only
Smartwatch Sync Apple Watch + Wear OS Apple/Google Fit only Fitbit + Apple Limited No
AI Pattern Detection GPT-4 weekly reports Basic analytics Meal IQ only None Gamified only
Auto PDF Reports One-click export CSV + basic PDF Premium PDF Provider reports No
Care Team Sharing Built-in No No Clinic-focused Diabuddies
Family / Multi-profile Up to 4 profiles Single user Single user Single user Limited
Water & Lifestyle Tracking Built-in No No No No
Offline Mode Full functionality Limited No No No
Clinic Dashboard $49/mo B2B No No Enterprise only No

Competitor pricing and features based on publicly available information as of 2026. Glooko is free for patients but enterprise-priced for clinics.

For Health Systems

Built for the stakeholders who carry the burden.

GlucoToq is not a consumer gadget. It is a population health infrastructure tool designed for Ministries of Health, hospital networks, and insurance providers across the Pacific and beyond.

✓

Population Dashboards

Real-time visibility into thousands of patients. Identify high-risk cohorts before they hit the ER. Designed for island health networks with limited specialist coverage.

✓

Reduce Hospitalizations

Early pattern detection prevents DKA, severe hypoglycemia, and foot ulcers — the most expensive complications. Our Fiji pilot saw a 40% drop in DKA admissions.

✓

Close the Diagnosis Gap

Community screening integration + remote monitoring brings undiagnosed patients into care pathways faster. Critical when 42% of Pacific diabetics don't know they have it.

✓

Works on Low Connectivity

Full offline functionality with smart sync when 3G/4G returns. Built for rural Pacific islands where connectivity is intermittent but diabetes is relentless.

✓

HIPAA & GDPR Ready

End-to-end encryption. Compliance architecture for USA, EU, Australia, and Pacific health systems. Data sovereignty options for national health ministries.

CGM continuous glucose monitor on patient arm
Continuous monitoring is the future of diabetes care. GlucoToq makes it accessible and intelligent — even on a remote island.

The pandemic is here.
The solution is ready.

Join health systems in Fiji, Australia, New Zealand, and the Pacific in deploying the next generation of diabetes management.